EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Enlarged cavum septum pellucidum and small thymus as markers for 22q11.2 deletion syndrome

Kimberly B Gaiser, Erica M Schindewolf, Laura J Conway, Beverly G Coleman, Edward R Oliver, Jack R Rychik, Suzanne E Debari, Donna M Mcdonald-Mcginn, Elaine H Zackai, Julie S Moldenhauer, Juliana S Gebb iD

Prenatal Diagnosis · 2024

DOI: 10.1002/pd.6555 ↗

At a glance

Journal article in Prenatal Diagnosis, 2024. Written by Kimberly B Gaiser and 10 co-authors. Institution: Division of Human Genetics, The 22q and You Center and Clinical Genetic Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Thymus Gland, DiGeorge Syndrome, Ultrasonography, Prenatal, Septum Pellucidum. Cited 6 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Enlarged cavum septum pellucidum (CSP) and hypoplastic thymus are proposed extra‐cardiac fetal markers for 22q11.2 deletion syndrome. We sought to determine if they were part of the fetal phenotype of our cohort of fetuses with 22q11.2 deletion syndrome.

Methods

Case‐control study of fetuses evaluated from 2016 to 2022. The study group included fetuses with laboratory confirmation of 22q11.2 deletion syndrome. The control group included pregnancies with conotruncal cardiac anomalies with normal microarray as well as structurally normal fetuses with normal microarray. The CSP and thymus were routinely measured during anatomical ultrasound in all patients at their initial visit at 27.1 ± 4.7 weeks. The CSP and thymus measurements were classified as abnormal if they were >95% or

Subjects

MeSH terms (MEDLINE)

Thymus GlandDiGeorge SyndromeUltrasonography, PrenatalSeptum PellucidumHumansFemalePregnancyCase-Control StudiesAdultBiomarkersRetrospective Studies

Substances

Biomarkers

Authors and institutions

  • Division of Human Genetics, The 22q and You Center and Clinical Genetic Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Division of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Fetal Heart Program, Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

ORCID profiles: Juliana S Gebb

Cite

APA

Gaiser, K. B., Schindewolf, E. M., Conway, L. J., Coleman, B. G., Oliver, E. R., Rychik, J. R., Debari, S. E., Mcdonald-Mcginn, D. M., Zackai, E. H., Moldenhauer, J. S., & Gebb, J. S. (2024). Enlarged cavum septum pellucidum and small thymus as markers for 22q11.2 deletion syndrome. Prenatal Diagnosis. https://doi.org/10.1002/pd.6555

Vancouver

Gaiser KB, Schindewolf EM, Conway LJ, Coleman BG, Oliver ER, Rychik JR, et al. Enlarged cavum septum pellucidum and small thymus as markers for 22q11.2 deletion syndrome. Prenatal Diagnosis. 2024. doi:10.1002/pd.6555

BibTeX
@article{Gaiser2024,
  author = {Gaiser, Kimberly B and Schindewolf, Erica M and Conway, Laura J and Coleman, Beverly G and Oliver, Edward R and Rychik, Jack R and Debari, Suzanne E and Mcdonald-Mcginn, Donna M and Zackai, Elaine H and Moldenhauer, Julie S and Gebb, Juliana S},
  title = {Enlarged cavum septum pellucidum and small thymus as markers for 22q11.2 deletion syndrome},
  journal = {Prenatal Diagnosis},
  year = {2024},
  doi = {10.1002/pd.6555}
}
Start for free →